Enterprise Value
$1.68 B
+$68.74 M+4.27%
5 min ago
Summary:
Recursion Pharmaceuticals enterprise value is currently $1.68 billion, with a rise of +$68.74 million (+4.27%) during the most recent trading day. Over the past year, it has dropped by -$295.82 million (-14.99%). RXRX enterprise value is now -73.55% below its all-time high of $6.34 billion.RXRX Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RXRX Enterprise Value Performance
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | +4.3% | +3.5% | +3.5% |
| 1 m1 month | -10.8% | -9.2% | -9.2% |
| 3 m3 months | +19.0% | +15.3% | +15.1% |
| 6 m6 months | +2.8% | -0.1% | -2.1% |
| ytdytd | +4.3% | +3.5% | +3.5% |
| 1 y1 year | -15.0% | -12.9% | -29.0% |
| 5 y5 years | - | - | - |
RXRX Enterprise Value High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | $2.01 B | -16.7% | $1.40 B | +19.9% |
| 3 m | 3 months | $2.01 B | -16.7% | $1.33 B | +26.6% |
| 6 m | 6 months | $2.04 B | -17.6% | $1.30 B | +29.3% |
| 1 y | 1 year | $3.19 B | -47.5% | $1.30 B | +29.3% |
| 3 y | 3 years | $3.19 B | -47.5% | $411 M | +308.1% |
| 5 y | 5 years | $6.34 B | -73.5% | $411 M | +308.1% |
| alltime | all time | $6.34 B | -73.5% | $411 M | +308.1% |
Recursion Pharmaceuticals Enterprise Value History
| Date | Value |
|---|---|
| 2025 | $1.68 B(+4.3%) |
| 2024 | $1.61 B(-19.3%) |
| Date | Value |
|---|---|
| 2023 | $1.99 B(+113.6%) |
| 2022 | $933.76 M(-64.7%) |
| 2021 | $2.64 B |
FAQ
- What is Recursion Pharmaceuticals enterprise value?
- What is the all time high enterprise value for Recursion Pharmaceuticals?
- What is RXRX enterprise value year-to-date change?
- What is Recursion Pharmaceuticals enterprise value year-on-year change?
What is Recursion Pharmaceuticals enterprise value?
The current enterprise value of RXRX is $1.68 B
What is the all time high enterprise value for Recursion Pharmaceuticals?
Recursion Pharmaceuticals all-time high enterprise value is $6.34 B
What is RXRX enterprise value year-to-date change?
Recursion Pharmaceuticals enterprise value has changed by +$68.74 M (+4.27%) since the beginning of the year
What is Recursion Pharmaceuticals enterprise value year-on-year change?
Over the past year, RXRX enterprise value has changed by -$295.82 M (-14.99%)